MR Adenosine Perfusion in the functional evaluation of patients undergoing PCI for single or two vessel disease

MR Adenosine Perfusion in the functional evaluation of patients undergoing PCI for single or two vessel disease - MAPPCI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29951

Enrollment

Registered

2006-10-12

Start date

2006-07-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary atherosclerosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: single or two-vessel coronary artery disease

Exclusion criteria

Exclusion criteria: COPD asthma persantin usage Non-MR compatible implants claustrophobia second and third degree heart block Sick-sinus syndrome severe hypotension heart failure prolonged QT-time Pregnancy

Design outcomes

Primary

Measure	Time frame
The presence of visual or measurable reversible perfusiondefects	—

Secondary

Measure	Time frame
Agreement between adenosine perfusion MR with CAG and FFR-measurements. qualitative versus quantitative assessment of myocardial perfusion. Quantifying the effect of PCI on left ventricular function. Feasibility of TSENSE sequence in an adenosine perfusion MR protocol	—

Countries

Netherlands

Outcome results